FDA inspection
Quay Pharmaceuticals: FDA inspection ending Oct 14, 2022
FDA inspection 1191495 · No Action Indicated (NAI) · Deeside
Key facts
| Inspection ID | 1191495 |
|---|---|
| Firm | Quay Pharmaceuticals |
| FEI number | 3009530711 |
| Address | Unit 28, Parkway |
| City | Deeside |
| Fiscal year | 2023 |
| Inspection end date | Oct 14, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data